Shopping Cart
Remove All
Your shopping cart is currently empty
ATR-258 is a GRK2-biased partial agonist of β2AR. It acts as a competitive antagonist of β1AR and exhibits weak partial agonist activity on β3AR at a concentration of 10 μM. ATR-258 enhances glycemic control and reduces lipid accumulation in obese mice with minimal side effects. It is applicable in research on type 2 diabetes (T2DM).


| Description | ATR-258 is a GRK2-biased partial agonist of β2AR. It acts as a competitive antagonist of β1AR and exhibits weak partial agonist activity on β3AR at a concentration of 10 μM. ATR-258 enhances glycemic control and reduces lipid accumulation in obese mice with minimal side effects. It is applicable in research on type 2 diabetes (T2DM). |
| Molecular Weight | 212.26 |
| Formula | C11H17FN2O |
| Cas No. | 2301983-88-8 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.